Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    chronic obstructive pulmonary disease | NCT01136239
Show Display Options
Rank Status Study
1 Unknown  The Effect of High Dose N-acetylcysteine on Airtrapping and Airway Resistance in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: COPD
Interventions: Drug: N-acetycysteine (600mg twice daily);   Drug: Placebo

Indicates status has not been verified in more than two years